Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Oncology|April 30, 2003
Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaDonna Weber, Steven P Treon, Christos Emmanouilides, et al.
Genes, Chromosomes & Cancer|December 1, 2010
High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survivalAnna M Halldórsdóttir, Birgitta Sander, Hanna Göransson, et al.
International Journal of Cancer|June 12, 2008
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activationKristin Gustafsson, Xiao Wang, Denise Severa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 27, 2005
Pharmacogenetics of cyclophosphamide in patients with hematological malignanciesHanjing Xie, Laimonas Griskevicius, Lars Ståhle, et al.
Scientific Reports|March 8, 2013
SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expressionAgata Magdalena Wasik, Martin Lord, Xiao Wang, et al.
Medical Oncology (Northwood, London, England)|May 18, 2021
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomasDaniel Tesfa, Birgitta Sander, Henric Lindkvist, et al.
International Journal of Cancer|May 19, 2005
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1Birgitta Sander, Jenny Flygare, Anna Porwit-Macdonald, et al.
Investigational New Drugs|December 21, 2007
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemiaMarkus Jensen, Andreas Engert, Florian Weissinger, et al.
British Journal of Haematology|August 18, 2020
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)Alden Alberto Moccia, Sämi Schär, Stefanie Hayoz, et al.
British Journal of Haematology|December 1, 2011
Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up timesBjörn E Wahlin, Olav E Yri, Eva Kimby, et al.
Pageof 12